Although it is interesting to speculate whether iron deficiency found in PV patients will translate to a lower dose endogenous hepcidin-inducer requirement relative to diseases of iron overload (e.g. β-thalassemia), no current data to inform this is available. The gene discussed is HAMP; the disease is Iron deficiency anemia.